North America Antimicrobial Susceptibility Testing Market (2024-2029)
The North America Antimicrobial Susceptibility Testing Market was valued at $1680.4 Million in 2024 and projected to reach to $2116.9 Million by 2029, representing a compound annual growth rate of 4.7%. The North America antimicrobial susceptibility testing market is positioned for steady growth, expanding from $1,680.4 million in 2024 to $2,116.9 million by 2029 at a 4.7% CAGR.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Antimicrobial Susceptibility Testing Market Trends and Insights
- North America's advanced healthcare infrastructure, high prevalence of antibiotic-resistant infections, and strong regulatory frameworks drive demand for rapid and accurate susceptibility testing solutions.
- In 2024, North America represents a mature market with significant adoption of automated and molecular testing platforms across clinical laboratories and diagnostic centers. Growth in North America is fueled by increasing antimicrobial resistance (AMR) awareness, rising healthcare expenditures, and integration of digital diagnostics in hospital systems.
- North America's emphasis on infection prevention and control protocols, combined with reimbursement support for advanced diagnostic testing, accelerates market expansion through 2029.
- The region's leading diagnostic manufacturers and research institutions continue to innovate, positioning North America as a key driver of global market trends in antimicrobial susceptibility testing..
Key Market Statistics
- CAGR (2024-2029) 4.7% CAGR
- Market Size, 2024 ~USD 1680.4 Million
- Forecast, 2029 ~USD 2116.9 Million
- Geography North America
North America Antimicrobial Susceptibility Testing Market Overview
Market Leadership :
North America commands the largest share of the global antimicrobial susceptibility testing market, driven by the US market valued at $1,884.6 million in 2024, representing over 112% of the regional total when combined with Canada's $232.3 million contribution.
Antibiotic Resistance Crisis :
The region faces escalating antibiotic-resistant infection rates, compelling healthcare providers to adopt rapid susceptibility testing solutions for precise pathogen identification and targeted treatment protocols.
Regulatory Excellence :
Stringent FDA regulations and healthcare compliance standards in North America mandate advanced diagnostic capabilities, creating sustained demand for validated and certified antimicrobial susceptibility testing platforms.
Healthcare Infrastructure Investment :
North America's sophisticated hospital networks, diagnostic laboratories, and research institutions invest heavily in cutting-edge testing technologies, supporting consistent market expansion at 4.7% CAGR through 2029.
North America Antimicrobial Susceptibility Testing Market Dynamics
- This growth trajectory reflects the region's commitment to combating antimicrobial resistance through advanced diagnostic infrastructure and clinical adoption of rapid testing methodologies. Key drivers include increasing prevalence of multidrug-resistant organisms, heightened awareness among healthcare professionals, and substantial investments in laboratory automation.
- The US market dominance, coupled with Canada's growing diagnostic capabilities, ensures North America remains a critical hub for susceptibility testing innovation and implementation across clinical and research settings..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- North America's antimicrobial susceptibility testing market will grow from $1,680.4M (2024) to $2,116.9M (2029) at a 4.7% CAGR.
- North America's mature healthcare infrastructure and high AMR burden support sustained demand for advanced diagnostic solutions.
- Automation and molecular testing technologies are increasingly adopted across North America's clinical laboratory networks.
- North America's regulatory environment and reimbursement policies create favorable conditions for market expansion through 2029.
Antimicrobial Susceptibility Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LAB INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | QUALITATIVE METHODS (Method) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 5.68 (2029) |
| Segments Covered | Product, Type, Method, Application, End User |
North America Antimicrobial Susceptibility Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Lab Disposables
- Lab Instruments
By Type
- Agar Dilution
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Antiviral Susceptibility Testing
- Automated Ast
- Automated Laboratory Instruments
- Broth Macrodilution
- Culture & Growth Media
- Culture And Growth Media
- Disk Diffusion
- Etest Method
- Genotypic Method
- Mic Strips
- Molecular Diagnostics Systems
- Susceptibility Plates
- Susceptibility Testing Disks
By Method
- Qualitative Methods
- Quantitative Methods
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology
- Other Applications
By End User
- Academic & Research Institutes
- Cros
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
Target Audience
- Diagnostic Equipment Manufacturers : Manufacturers need North America-specific market data to develop region-tailored AST platforms, understand FDA pathways, and identify distribution partnerships with major US and Canadian laboratory networks.
- Clinical Laboratory Directors : Laboratory leaders require insights into emerging testing methodologies, automation technologies, and cost-effectiveness analyses to optimize their susceptibility testing workflows and improve turnaround times.
- Hospital Procurement Teams : Procurement professionals need competitive pricing analysis, vendor performance benchmarks, and ROI projections specific to North American healthcare systems to make informed equipment and service acquisition decisions.
- Pharmaceutical & Biotech Companies : Drug developers need market intelligence on antibiotic resistance patterns, testing adoption rates, and clinical trial requirements in North America to guide antimicrobial drug development and commercialization strategies.
- Healthcare Investors & Consultants : Investment professionals and management consultants require detailed market forecasts, growth drivers, and competitive positioning data to evaluate opportunities in North America's diagnostic testing sector.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 1884.6 Million |
| Canada | USD 232.3 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into the US ($1,884.6M) and Canadian ($232.3M) markets separately, enabling targeted business strategies and investment decisions specific to each North American market segment.
- Competitive Landscape Analysis : Understand the competitive dynamics, key players, and market consolidation trends unique to North America's advanced healthcare ecosystem and regulatory environment.
- Growth Opportunity Identification : Identify high-potential segments within the 4.7% CAGR growth trajectory, including emerging technologies, automation solutions, and point-of-care testing platforms gaining traction in North American laboratories.
- Regulatory & Compliance Insights : Access comprehensive analysis of FDA approvals, clinical laboratory standards (CLIA), and compliance requirements driving adoption of susceptibility testing solutions across North American healthcare systems.
- Strategic Partnership Opportunities : Identify collaboration and acquisition targets among diagnostic manufacturers, hospital networks, and research institutions actively expanding their antimicrobial susceptibility testing capabilities in North America.
Frequently asked questions
What is the current size of the antimicrobial susceptibility testing market in North America?
In 2024, North America's antimicrobial susceptibility testing market is valued at $1,680.4 million, reflecting strong adoption of diagnostic testing across the region's healthcare systems.
What is the projected market size for North America by 2029?
North America's antimicrobial susceptibility testing market is forecast to reach $2,116.9 million by 2029, representing a 4.7% compound annual growth rate from 2024.
What factors are driving growth in North America's antimicrobial susceptibility testing market?
North America's market growth is driven by rising antimicrobial resistance prevalence, advanced healthcare infrastructure, strong regulatory support, and increasing adoption of automated and molecular testing platforms.
How does North America's market compare to global trends?
North America's 4.7% CAGR slightly exceeds the global average of 5%, reflecting the region's mature market status and established diagnostic infrastructure compared to emerging markets.
Which testing technologies are most prevalent in North America?
North America shows strong adoption of automated susceptibility testing systems, molecular diagnostics, and rapid phenotypic methods across clinical laboratories and hospital networks.
RESEARCH METHODOLOGY
In that respect, the research has heavily employed both primary and secondary sources in order to comprehensively study the forces influential in the industry. This methodology comprised market segmentation analysis, industry trends, major players, competitive landscape, key market dynamics, and strategies of key companies.
Secondary Research
The secondary research involves D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings for conducting secondary research in developing a database on major industry participants. Key data with regard to leading players, market segmentation, at a various level, industry trends by segments, significant mergers and acquisitions, and the impact of trends and technological perspectives related to the antimicrobial susceptibility testing market.
Primary Research
Primary research in the report included interviewing a cross-section, both from the demand and supply sides, to capture information qualitatively and quantitatively. Supply side: High-level executives' interviews, such as CEOs, VPs, marketing and sales directors, regional sales managers, and technology and innovation directors were contacted from leading companies and organizations in product therapy markets. On the demand side, research was carried out by discussing with professionals like clinicians, procurement managers, purchase managers, department heads, and experts from hospitals, diagnostic centers, pharmaceutical and biotechnological firms, and research and academic institutes. This was necessary to gain a proper view of the market segmentation, significant players in the market, and key trends and dynamics related to the growth of the market.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This research examines the Antimicrobial Susceptibility testing market and revenue share among the market leaders. It made use of a combination of primary and secondary research methods to do so. Primary research involved in-depth interviews with CEOs, directors, and senior marketing executives. Secondary research formed annual and financial reports by major industry players. The market value was determined while following a segment-based strategy, and it used revenue details of leading solution providers for differentiating between sources and services.
Covered segments:
Identify the major companies involved in the world Antimicrobial Susceptibility testing market and document their annual revenues or revenues from their particular product category/business division.
The revenue mapping of these leading competitors, based on 2024 data, captures a good share of the market and is thus extrapolated to estimate the total global value of the Antimicrobial Susceptibility testing market:
Data Triangulation
Based on the methodology, categorical and sub-categories segmentation of the global antimicrobial susceptibility testing market was performed. Further, data triangulation and the segmentation process were undertaken to arrive at an accurate data of different segments for the market. Various analyses involved factors and trends of the demand and supply sides. The integration of detailed top-down and bottom-up approaches offered a holistic overview of the antimicrobial susceptibility testing market
Market Definition
The Antimicrobial Susceptibility Testing market involves the diagnosis and determination of effectiveness against pathogens such as bacteria, fungi, and viruses using antimicrobial agents. It consists of several technologies and methodologies employed for the diagnosis of the susceptibility of microorganisms to a variety of antimicrobial agents through automated systems, molecular diagnostics, and traditional culture-based methods. The main aim of AST is to be able to choose appropriate therapy, enhance patient outcomes, and take against the threat of emerging antimicrobial resistance. The market includes products and services used by clinical laboratories, hospitals, research institutions, and other healthcare facilities.
Stakeholders
- Healthcare institutions (hospitals and clinics)
- Healthcare institutions (hospitals and diagnostic centers)
- Research institutions
- Clinical research organizations
- Academic medical centers and universities
- Reference laboratories
- Accountable Care Organizations (ACOs)
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Group Purchasing Organizations (GPOs)
- Medical Research Laboratories
- Academic Medical Centers and Universities
Report Objectives
- Define, describe, and project the antimicrobial susceptibility testing (AST) market across various dimensions, including product, type, methods, applications, end users, and regional areas.
- Explore opportunities for stakeholders and provide a detailed analysis of the competitive landscape, highlighting the key players in the market.
- Offer comprehensive insights into the principal factors influencing market growth.
- Analyze micro markets by evaluating individual growth trends, potential, and their contributions to the overall market.
- Monitor and review competitive developments such as new product launches, approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the AST sector.
Get the Full Antimicrobial Susceptibility Testing Market Report
Full forecast, segment splits, and company analysis for all Antimicrobial Susceptibility Testing Market.
- Canada Antimicrobial Susceptibility Testing Market
- US Antimicrobial Susceptibility Testing Market
- Germany Antimicrobial Susceptibility Testing Market
- France Antimicrobial Susceptibility Testing Market
- UK Antimicrobial Susceptibility Testing Market
- Italy Antimicrobial Susceptibility Testing Market
- Spain Antimicrobial Susceptibility Testing Market
- Japan Antimicrobial Susceptibility Testing Market
- China Antimicrobial Susceptibility Testing Market
- India Antimicrobial Susceptibility Testing Market
- Australia Antimicrobial Susceptibility Testing Market
- South Korea Antimicrobial Susceptibility Testing Market
- Brazil Antimicrobial Susceptibility Testing Market
- Mexico Antimicrobial Susceptibility Testing Market
- Rest Of Europe Antimicrobial Susceptibility Testing Market
- Rest Of Asia Pacific Antimicrobial Susceptibility Testing Market
- Rest Of Latin America Antimicrobial Susceptibility Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
